title: Complications of systemic chemotherapy as treatment of retinoblastoma.
authors.affiliation: Bascom Palmer Eye Institute, Miami, FL 33136, USA.
authors.forename: M S
authors.initials: MS
authors.lastname: Benz
authors.forename: I U
authors.initials: IU
authors.lastname: Scott
authors.forename: T G
authors.initials: TG
authors.lastname: Murray
authors.forename: D
authors.initials: D
authors.lastname: Kramer
authors.forename: S
authors.initials: S
authors.lastname: Toledano
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D007223:Infant; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D009503:Neutropenia / Q000139:chemically induced*; D009943:Organophosphorus Compounds / Q000008:administration & dosage; D019572:Retinal Neoplasms / Q000188:drug therapy*; D012175:Retinoblastoma / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D009943:Organophosphorus Compounds; D003561:Cytarabine; C061400:etoposide phosphate; D014750:Vincristine; D005047:Etoposide; D016572:Cyclosporine; D016190:Carboplatin; D008727:Methotrexate